The clinical outcome of multiple myeloma (MM) is heterogeneous. A simple and reliable tool is needed to stratify patients with MM. We combined the International Staging System (ISS) with chromosomal abnormalities (CA) detected by interphase fluorescent in situ hybridization after CD138 plasma cell purification and serum lactate dehydrogenase (LDH) to evaluate their prognostic value in newly diagnosed MM (NDMM).
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
PALUMBO, Antonio
First
;OLIVA, STEFANIA;CALTAGIRONE, Simona Angela;BRINGHEN, Sara;GAY, Francesca Maria;
2015-01-01
Abstract
The clinical outcome of multiple myeloma (MM) is heterogeneous. A simple and reliable tool is needed to stratify patients with MM. We combined the International Staging System (ISS) with chromosomal abnormalities (CA) detected by interphase fluorescent in situ hybridization after CD138 plasma cell purification and serum lactate dehydrogenase (LDH) to evaluate their prognostic value in newly diagnosed MM (NDMM).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Palumbo 2015 - R-ISS for MM - jco.2015.61.2267.pdf
Accesso aperto
Descrizione: Palumbo 2015 - R-ISS for MM - jco.2015.61.2267
Tipo di file:
PDF EDITORIALE
Dimensione
241.05 kB
Formato
Adobe PDF
|
241.05 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
